Ethical responsibility of phase 0 trials

Clinical Cancer Research

Volumn 15, Issue 3, 2009, Pages 1121-

  Arai, Roberto Jun ^a   Hoff, Paulo Marcelo Gehm ^a   De Castro Jr , Gilberto ^a   Stern, Arnold ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RESEARCH; CANCER THERAPY; DEVELOPING COUNTRY; HUMAN; LETTER; LOWEST INCOME GROUP; MEDICAL ETHICS; PRIORITY JOURNAL; TERMINAL DISEASE;

CLINICAL TRIALS AS TOPIC; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEDICAL ONCOLOGY; PATIENT SELECTION; RESEARCHER-SUBJECT RELATIONS;

EID: 61349194556     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1824     Document Type: Letter

References (4)

1. Abdoler E, Taylor H, Wendler D. The ethics of phase 0 oncology trials. Clin Cancer Res 2008;12:3692-7.
2. Elliott C, Abadie R. Exploiting a research underclass in phase 1 clinical trials. N Engl J Med 2008;358:2316-7.
3. Verastegui EL. Consenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico. BMC Med Ethics 2006;7:E13.
4. Hill TP. Phase 0 trials: are they ethically challenged? Clin Cancer Res 2007;13: 783-4.